|
GLG1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03792538400194E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.73249999480785E-08 |
| Normal-vs-Stage2 |
1.336440E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.381790E-03 |
| Stage1-vs-Stage2 |
5.809000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.858000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.935400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.62739846440741E-11 |
| Normal-vs-AfricanAmerican |
1.152040E-01 |
| Normal-vs-Asian |
4.929800E-02 |
| Caucasian-vs-AfricanAmerican |
2.368000E-01 |
| Caucasian-vs-Asian |
6.052000E-01 |
| AfricanAmerican-vs-Asian |
1.243780E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.49719999999565E-05 |
| Normal-vs-Female |
3.65679997393897E-09 |
| Male-vs-Female |
4.587400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79532999999843E-05 |
| Normal-vs-Extreme_Weight |
1.19300000001044E-06 |
| Normal-vs-Obese |
1.941970E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
8.691000E-01 |
| Normal_Weight-vs-Obese |
2.177400E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.163600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.367600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.96308000000034E-05 |
| Normal-vs-Age(61-80Yrs) |
4.6712000045801E-08 |
| Normal-vs-Age(81-100Yrs) |
2.895400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.293200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.617200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.072000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.953200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.567800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.812810E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
1.070010E-01 |
| Normal-vs-Grade 3 |
8.700000E-02 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
3.151000E-01 |
| Grade 2-vs-Grade 4 |
1.070010E-01 |
| Grade 3-vs-Grade 4 |
8.700000E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80610004729687E-09 |
| Normal-vs-N1 |
7.398700E-03 |
| N0-vs-N1 |
9.915200E-01 |
|
|
